Global HbA1c Testing Market, By Product Type (Instruments, Reagents and Kits), Technology (Ion-exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of HbA1c Testing Market
The HbA1c testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 2,770.83 million by 2028 and will grow at a CAGR of 11.62% in the above mentioned forecast period.
Hemoglobin A1C (HbA1c) is a type of hemoglobin that is bound to glucose. The HbA1c test helps to provide the patient with the average level of blood sugar only for the past two to three months. These tests are generally combined with other tests for the better results.
The rise in the number of research organizations and associations for diabetes is amongst the important factor expected to intensify the growth and demand of HbA1c testing market. In addition, the increase in the initiatives by key players and rise in the prevalence of diabetes are also expected contribute to the growth in the global market over the forecast period of 2021 to 2028. Also the rapid rise in the medical tourism and the increase in the demand for accurate measurement of HbA1c level are also likely to enhance the growth of the market. Furthermore, the increase in geriatric population and influence of sedentary lifestyle and unhealthy diet are also one of the significant factors expected to fuel the growth of the HbA1c testing market.
The rapid increase in the approvals and product launches and incorporation of various technologies in HbA1c testing instruments are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the limited indications of Hba1c tests and strict reimbursement policies in developing countries are expected to curb the growth of the HbA1c testing market, whereas the rise in accuracy concern among population can challenge the growth of the HbA1c testing market.
This HbA1c testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the HbA1c testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global HbA1c Testing Market Scope and Market Size
The HbA1c testing market is segmented on the basis of product type, technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the HbA1c testing market is segmented into instruments and reagents and kits. Instruments have further been segmented into bench-top device and handheld device.
- Based on technology, the HbA1c testing market is segmented into ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay and others.
- The end user segment of the HbA1c testing market is segmented into hospitals and clinics, diagnostic laboratories, homecare, research institution and others.
HbA1c Testing Market Country Level Analysis
The HbA1c testing market is analyzed and market size insights and trends are provided by country, product type, technology and end user as referenced above.
The countries covered in the HbA1c testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the HbA1c testing market owing to the rise in activities such as research, awareness campaigns and increase in the joint ventures by public and private organizations in the US and Canada. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapid development in the healthcare infrastructure and increase in the per capita disposable incomes.
The country section of the HbA1c testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The HbA1c testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for HbA1c testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the HbA1c testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and HbA1c Testing Market Share Analysis
The HbA1c testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HbA1c testing market.
The major players covered in the HbA1c testing market report are Abbott, Bio-Rad Laboratories, Inc., ARKRAY, Inc., Danaher, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, TransAsia Bio-Medicals, Trinity Biotech Ireland, EKF Diagnostics, Randox Laboratories Ltd., HemoCue India, Eurolyser Diagnostica GmbH, Sekisui Diagnostics, Healio, Diazyme Laboratories, Inc., Beckman Coulter, Inc., A. Menarini Diagnostics srl, SEBIA, PTS Diagnostics and DiaSys Diagnostic Systems GmbH among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.